IFIH1 and dermatomyositis: Although an increase in IFIH1 autoantibodies (anti-MDA5 antibodies) have not been reported in T1D, it may be of interest to assess in future studies if Ifih1R/R impacts development of these autoantibodies, which are deleterious in patients with dermatomyositis (44).